Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A chronic inflammatory disease that affects the central nervous system, multiple sclerosis (MS) is one of the leading causes of neurologic disability in young and middle-aged adults.

Drug Criteria & Outcomes: The dangerous fight against plaque: The use of natalizumab in the treatment of multiple sclerosis